Privia Health Group, Inc. (PRVA) Stock Score, Valuation & Financial Research
Privia Health Group, Inc. is in the Healthcare sector and Medical - Healthcare Information Services industry. It is reviewed using Wall Street Score's company-strength, valuation, growth and financial-health framework. The current Wall Street Score is 40/100.
Quick answer for PRVA
Privia Health Group, Inc. currently has a Wall Street Score of 40/100. The stored market price is $20.42. Its financial score is 54/100. Its valuation score is 0/100. These figures are a research snapshot, not a buy or sell recommendation.
What Privia Health Group, Inc. does
Privia Health Group, Inc. functions as a national entity focused on empowering physicians throughout the United States. It partners with medical groups, health plans, and health systems, with the primary objective of optimizing physician practices, enhancing patient experiences, and appropriately compensating clinicians for care delivered both virtually and in person. To achieve this, Privia offers a comprehensive suite of services. These include technology and population health tools designed to streamline independent providers' workflows; a Management Services Organization (MSO) that alleviates administrative tasks, freeing providers to focus on clinical care; a single-TIN medical group, which bolsters payer negotiations, facilitates clinical integration, and aligns financial incentives; an Accountable Care Organization (ACO) designed to engage patients, reduce inefficient utilization,
PRVA financial snapshot
- Wall Street Score:
- 40/100
- Current price:
- $20.42
- Market capitalization:
- $2.57B
- Revenue:
- $2.25B
- Net income:
- $21.8M
- Free cash flow:
- $162.2M
- Cash:
- $419.5M
- Total debt:
- $9.0M
- EPS:
- 0.19
- P/E ratio:
- 107.5x
- Financial score:
- 54/100
- Valuation score:
- 0/100
- Revenue score:
- 25/100
What stands out
- Reported year-over-year revenue growth is +0.1%.
- Free cash flow is $162.2M, showing positive cash generation.
- The balance sheet shows $419.5M of cash versus $9.0M of total debt, leaving more cash than debt.
What the numbers mean
Its current valuation score is 0/100, which Wall Street Score classifies as weak within the model's valuation framework.
The financial score is 54/100. This is a starting point for reviewing liquidity, leverage and cash-flow strength rather than a stand-alone recommendation.
A strong company and an attractive stock price are not always the same thing. Revenue, earnings, free cash flow, debt, management quality, competitive advantage and valuation should be considered together. Wall Street Score organizes these inputs into a consistent research framework so investors can identify what deserves deeper review.
Data freshness: Financial data last refreshed 2026-07-24.
How to research PRVA
Start by understanding how the company makes money. Then compare revenue and earnings trends, cash generation, debt, liquidity and valuation. Review the company's latest filings and earnings reports before acting on any score or model estimate.
Learn how to analyze a stock · Read the Wall Street Score methodology · Browse other stocks
Data may change as company filings and market prices update. Educational research only; not a buy or sell recommendation.